Evidence map›Paper›PMID 37441496›Full record

Trial reportFrontiers in endocrinology2023

Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial.

Sílvia Ballesta, Juan J Chillarón, Yolanda Inglada, Elisenda Climent, Gemma Llauradó, Juan Pedro-Botet, Francesc Cots, Helena Camell, Juana A Flores, David Benaiges

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04758884 (Telemedicine in Patients With Type 1 Diabetes Mellitus. Efficacy Study of a Specific Virtual Consultation.), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04758884 nacompletednot on this map

Telemedicine in Patients With Type 1 Diabetes Mellitus. Efficacy Study of a Specific Virtual Consultation.

TypeinterventionalSponsorConsorci Sanitari de l'Alt Penedès i GarrafRan2021 to 2022Enrolled55ConditionsDiabetes Mellitus, Type 1ArmsTelemedicine
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Could Online Education Replace Face-to-Face Education in Diabetes? A Systematic Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Sílvia BallestaEndocrinology and Nutrition, Consorci Sanitari de l'Alt Penedès Garraf, Vilafranca del Penedès, Spain.
Juan J ChillarónEndocrinology and Nutrition, Consorci Sanitari de l'Alt Penedès Garraf, Vilafranca del Penedès, Spain.
Yolanda IngladaEndocrinology and Nutrition, Consorci Sanitari de l'Alt Penedès Garraf, Vilafranca del Penedès, Spain.
Elisenda ClimentEndocrinology and Nutrition, Hospital del Mar, Barcelona, Spain.
Gemma LlauradóEndocrinology and Nutrition, Hospital del Mar, Barcelona, Spain.
Juan Pedro-BotetEndocrinology and Nutrition, Hospital del Mar, Barcelona, Spain.
Francesc CotsManagement Control Department, Hospital del Mar, Barcelona, Spain.
Helena CamellInternal Medicine, Hospital Comarcal de l´Alt Penedès, Vilafranca del Penedès, Spain.
Juana A FloresEndocrinology and Nutrition, Consorci Sanitari de l'Alt Penedès Garraf, Vilafranca del Penedès, Spain.
David BenaigesEndocrinology and Nutrition, Consorci Sanitari de l'Alt Penedès Garraf, Vilafranca del Penedès, Spain.
Hospital Del Mar · ESUniversitat Pompeu Fabra · ESConsorci Sanitari Garraf · ESHospital Comarcal de Inca · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Increasing evidence indicates that the telehealth (TH) model is noninferior to the in-person approach regarding metabolic control in type 1 diabetes (T1D) and offers advantages such as a decrease in travel time and increased accessibility for shorter/frequent visits. The primary aim of this study was to compare the change in glycated hemoglobin (HbA Research design and methods: Randomized controlled, open-label, parallel-arm study among adults with T1D. Participants were submitted to in-person visits at baseline and at months 3 and 6 (conventional group) or teleconsultation in months 1 to 4 plus 2 in-person visits (baseline and 6 months) (TH group). Mixed effects models estimated differences in HbA Results: Fifty-five participants were included (29 conventional/26 TH). No significant differences in HbA Conclusions: The TH model is comparable to in-person visits regarding HbA

Indexed as

Diabetes Mellitus, Type 1TelemedicineAdultBlood GlucoseGlycated HemoglobinHumansQuality of LifeBlood GlucoseGlycated Hemoglobinchronic complicationsemerging technologiesmetabolic controltelehealthtype 1 diabetes

Identifiers

PMID37441496
PMCPMC10333924
OpenAlexW4382466945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.